Tumor necrosis factor-α induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord

Neurobiology of Disease

Volumn 8, Issue 4, 2001, Pages 590-599

  Hermann, Gerlinda E ^a   Rogers, Richard C ^a   Bresnahan, Jacqueline C ^a   Beattie, Michael S ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

cFOS; Cytokines; Excitotoxic cell death; Glutamate; Microglia; Spinal cord injury

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; ALBUMIN; AMPA RECEPTOR AGONIST; CYTOKINE; GLUTAMIC ACID; KAINIC ACID; PROTEIN C FOS; TUMOR NECROSIS FACTOR ALPHA;

AMINO ACID BRAIN LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ELECTROPHYSIOLOGY; BRAIN INJURY; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; IMMUNOPOTENTIATION; MALE; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT; SENSORY NERVE CELL; SPINAL CORD; TISSUE INJURY;

EID: 0034877451     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2001.0414     Document Type: Article

References (47)

1. Microglial activation by Alzheimer amyloid precursor protein and modulation by apolipoprotein E
2. Cell death, repair, and recovery of function after spinal cord contusion injuries in rats
3. Endogenous repair after spinal cord contusion injuries in the rat
4. Traumatic spinal cord injury induces nuclear factor-B activation
5. Systemically administered interleukin-10 reduces tumor necrosis factor-alpha production and significantly improves functional recovery following traumatic spinal cord injury in rats
6. Neuromodulatory effects of CRF on cerebellar purkinje cells: An in vivo study in the cat
7. Neuroprotective effects of interleukin-10 following excitotoxic spinal cord injury
8. Histochemical effects of kainic acid on neostriatal dopamine and acetylcholinesterase
9. Tumor necrosis factor alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures
10. Glutamate receptors and the induction of excitotoxic neuronal death
11. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys
12. α activates solitary nucleus neurons responsive to gastric distention
13. A potential role for excitotoxins in the pathophysiology of spinal cord injury
14. Neurotoxic effects of tumor necrosis factor-alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype - Implications for AIDS neuropathogenesis
15. Tumor necrosis factor-alpha has morphological effects within the dorsal columns of the spinal cord, in contrast to its effects in the peripheral nervous system
16. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury
17. α in the dorsal vagal complex suppresses gastric motility
18. A single minute lesion around the ventral respiratory group in medulla produces fatal apnea in cats
19. Cell volume in the CNS: Regulation and implications for nervous system function and pathology
20. Selective degeneration of inhibitory interneurons in the rat spinal cord induced by intrathecal infusion of acromelic acid
21. Cytokine chemokine expression in contused rat spinal cord
22. Neurotoxicity of glutamate at the concentration released upon spinal cord injury
23. NMDA and non-NMDA receptor antagonists protect against excitotoxic injury in the rat spinal cord
24. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity
25. Multiple classes of the oligodendrocyte lineage are highly vulnerable to excitotoxicity
26. Stimulation of the nucleus raphe obscurus produces marked serotonin release into the dorsal medulla of fed but not fasted rats - Glutamatergic dependence
27. Role of microglial-derived tumor necrosis factor in mediating CD14 transcription and nuclear factor kappa B activity in the brain during endotoxemia
28. Lipopolysaccharide-induced microglial activation in culture: Temporal profiles of morphological change and release of cytokines and nitric oxide
29. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia
30. Upregulation of tumor necrosis factor alpha transport across the blood-brain barrier after acute compressive spinal cord injury
31. Alteration in extracellular amino acids after traumatic spinal cord injury
32. Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate
33. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function
34. Distribution and neurochemical phenotypes of caudal medullary neurons activated to express cFOS following peripheral administration of cholecystokinin
35. 2, 3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline reduces glial loss and acute white matter pathology after experimental spinal cord contusion
36. Cytokines - Killers in the brain?
37. Cytokine-induced acute inflammation in brain and spinal cord
38. Apoptosis of microglia and oligodendrocytes after spinal cord contusion in rats
39. Vagally-regulated gastric motor activity: Evidence for kainate and NMDA receptor mediation
40. Production of tumor necrosis factor in spinal cord following traumatic injury in rats
41. Dose-dependent reduction of tissue loss and functional impairment after spinal cord trauma with the AMPA-kainate antagonist NBQX
42. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors
43. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma
44. Methylprednisolone inhibition of TNF-alpha expression and NF-kappa B activation after spinal cord injury in rats
45. Sequential expression of c-fos protooncogene, TNF-alpha, and dynorphin genes in spinal cord following experimental traumatic injury
46. Activation of the parapyramidal region in the ventral medulla stimulates gastric acid secretion through vagal pathways in rats
47. Excitotoxic spinal cord injury: Behavioral and morphological characteristics of a central pain model